End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38,400 KRW | +0.52% | +6.22% | -13.71% |
04-05 | Nomura Adjusts DukSan Neolux’s Price Target to KRW56,000 From KRW54,000, Keeps at Buy | MT |
2023 | Tranche Update on DukSan Neolux Co.,Ltd's Equity Buyback Plan announced on March 2, 2022. | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 53% by 2026.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
Weaknesses
- With an enterprise value anticipated at 4530.09 times the sales for the current fiscal year, the company turns out to be overvalued.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.71% | 682M | - | ||
+14.02% | 63.38B | A- | ||
-3.80% | 46.51B | A- | ||
+13.26% | 39.91B | B+ | ||
+19.57% | 25.57B | A- | ||
+8.22% | 18.95B | C+ | ||
-1.13% | 17.58B | B+ | ||
-21.03% | 16.1B | A- | ||
+1.06% | 14.98B | B+ | ||
-16.73% | 14.78B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- A213420 Stock
- Ratings DukSan Neolux Co.,Ltd